Stocks · Healthcare · Medical - Care Facilities
The Joint Corp. JYNT
$7.28 -2.54% Close, Oct 2, 2026 · NASDAQ · Market cap $103.8M
High qualityInexpensive vs sectorLow risk
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $58.5M, up 220.6% from a year earlier.
- At 27.5× trailing earnings, the shares trade at the lowest P/E of the company's past five years.
- Operating margin widened to 2.5% from -6.4% a year earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 6%
- FCF growth (TTM, YoY)Top 41%
- Revenue growth, 3-year CAGRBottom 8%
- Revenue growth accelerationBottom 39%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 24%
- Gross marginTop 30%
- Operating marginTop 38%
- Cash conversion (OCF / net income)Bottom 42%
- Accruals (lower is better)Bottom 30%
- Net debt / EBITDA (lower is better)Top 6%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 15%
- Free-cash-flow yieldTop 22%
- EBITDA / enterprise valueTop 24%
- Sales / enterprise valueTop 16%
- P/E vs own 5-year history (lower is better)Top 6%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 29%
- 6-month returnBottom 27%
- 1-year return vs S&P 500Bottom 28%
- Distance from 52-week highTop 50%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 8%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 28%
- Upside to consensus price targetTop 23%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 11%
- Maximum drawdown, 3 yearsTop 33%
- Beta vs S&P 500 (lower is better)Top 49%
- Net debt / EBITDA (lower is better)Top 6%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 221.8% | 220.6% | ↓ |
| Gross margin | 35.8% | 81.1% | ↑ |
| Operating margin | -6.4% | 2.5% | ↑ |
| FCF margin | 18.5% | 7.2% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 220.6% | 221.8% | ↓ | Top 6% |
| Gross margin | 81.1% | 35.8% | ↑ | Top 30% |
| Operating margin | 2.5% | -6.4% | ↑ | Top 38% |
| Net margin | 6.5% | -26.4% | ↑ | — |
| Free-cash-flow margin | 7.2% | 18.5% | ↓ | — |
| Return on invested capital | 5.0% | — | Top 24% | |
| Revenue growth, 3-year CAGR | -18.5% | — | Bottom 8% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.42×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -3.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.8%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -234.4 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -5.24×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 12.03%
- Shareholder yield
- 12.03%
- Share count change, 1 year
- -7.5%
- Share count change, 3-year CAGR
- -1.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 7, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- +91.3%
- Average 2-day reaction, last 8
- -1.0%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $20.00
- Target vs current price
- +174.7%
- Analysts with a rating
- 8
- Share rating Buy or Strong Buy
- 63%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | -121.4% | -1.3% | +4.2% | -1.1% | — |
| May 7, 2026 | +166.7% | -1.5% | -5.7% | -6.5% | -6.7% |
| Mar 12, 2026 | +20.0% | -3.5% | -1.6% | +3.6% | -2.6% |
| Nov 6, 2025 | +300.0% | -3.7% | +0.7% | +1.9% | +21.0% |
| Aug 7, 2025 | +14.3% | -3.9% | -1.1% | -4.2% | -29.1% |
| May 8, 2025 | -50.0% | +5.9% | +0.4% | +23.8% | +12.5% |
| Mar 13, 2025 | +0.0% | +0.2% | +18.2% | +1.7% | +14.2% |
| Nov 7, 2024 | +2731.6% | -0.6% | -3.3% | -2.5% | -4.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.01 | $0.05 | -121.4% | $15.2M |
| May 7, 2026 | $0.08 | $0.03 | +166.7% | $14.8M |
| Mar 12, 2026 | $0.06 | $0.05 | +20.0% | $15.2M |
| Nov 6, 2025 | $0.02 | -$0.01 | +300.0% | $13.4M |
| Aug 7, 2025 | -$0.06 | -$0.07 | +14.3% | $13.3M |
| May 8, 2025 | -$0.03 | -$0.02 | -50.0% | $13.1M |
| Mar 13, 2025 | $0.06 | $0.06 | +0.0% | $14.4M |
| Nov 7, 2024 | $0.04 | -$0.00 | +2731.6% | $30.2M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 27.5× | 64.0× | 0th | Top 15% |
| P/E (forward) | 30.3× | — | — | — |
| EV / EBITDA | 21.8× | — | — | Top 24% |
| EV / Sales | 1.43× | — | — | Top 16% |
| Free-cash-flow yield | 4.07% | — | — | Top 22% |
| Earnings yield | 3.64% | — | — | Top 15% |
P/E over the past five years
Range 31.4× – 430.4× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -3.5%
- 200-day average slope (20 days)
- -0.4%
- Distance from 50-day average
- -12.2%
- Distance from 200-day average
- -17.1%
- RSI (14)
- 27.1
- Relative volume
- 0.91×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 31.1%
- Volatility vs own 5-year history
- 2th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.09
- Correlation with S&P 500
- 0.43
- Current drawdown from 1-year high
- -30.9%
- Maximum drawdown, 3 years
- -58.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 3, 2021 | Oct 2, 2026 | -93.2% | 1274 days | Not yet recovered |
| Aug 6, 2021 | Aug 19, 2021 | -19.6% | 9 days | 10 days (Sep 2, 2021) |
| Apr 28, 2021 | May 13, 2021 | -15.3% | 11 days | 7 days (May 24, 2021) |
| Mar 3, 2021 | Mar 9, 2021 | -14.9% | 4 days | 22 days (Apr 9, 2021) |
| Jul 12, 2021 | Jul 30, 2021 | -10.8% | 14 days | 4 days (Aug 5, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $103.8M
- P/E (TTM)
- 27.5
- EPS, diluted (TTM)
- $0.27
- Revenue (TTM)
- $58.5M
- 52-week range
- $7.21 – $10.67
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $80.0M | $101.3M | $47.0M | $52.2M | $54.9M |
| Gross profit | $72.3M | $92.1M | $36.5M | $40.6M | $43.7M |
| Operating income | $6.1M | $828,254 | $318,299 | -$1.9M | -$905,478 |
| Net income | $7.6M | $626,705 | -$9.8M | -$5.8M | $2.9M |
| EPS (diluted) | $0.44 | $0.04 | -$0.66 | -$0.39 | $0.19 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $30.2M | -$38.3M | $13.1M | $13.3M | $13.4M | $15.2M | $14.8M | $15.2M |
| Net income | -$3.2M | -$2.7M | $967,796 | $93,363 | $855,009 | $991,097 | $1.3M | $653,021 |
| EPS (diluted) | -$0.21 | -$0.18 | $0.05 | $0.01 | $0.06 | $0.07 | $0.09 | $0.05 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $13.8M | $8.2M | $14.7M | $9.4M | $1.8M |
| Capital expenditure | -$7.0M | -$5.9M | -$5.0M | -$1.2M | -$1.5M |
| Free cash flow | $6.9M | $2.3M | $9.7M | $8.2M | $334,724 |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $0 | -$5,804 | $198,553 | $24,125 | -$9.8M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $22.2M
- Total assets
- $51.6M
- Total liabilities
- $35.8M
- Total debt
- $2.0M
- Net debt
- -$20.1M
- Shareholders’ equity
- $15.9M
As of Jun 30, 2026 (filed Aug 7, 2026).
Short interest
- Shares sold short
- 439,478
- Days to cover
- 4.89
- Change vs previous report
- +10.0%
FINRA short interest, settlement date Sep 15, 2026.